Recombinant Human DLEU1 Protein，GST

DLEU1, or the Deleted in Lymphocytic Leukemia 1 gene, is a notable long non-coding RNA (lncRNA) located on chromosome 13q14, which has garnered attention due to its potential involvement in various malignancies, particularly in B-cell chronic lymphocytic leukemia (CLL). The gene is known to play a regulatory role in important biological processes, including cell proliferation, survival, and apoptosis, implicating its function in tumorigenesis and cancer progression. Studies have demonstrated that DLEU1 can influence the expression of adjacent protein-coding genes and is often found to be downregulated in cancers, suggesting its role as a tumor suppressor. The exploration of DLEU1 as a recombinant protein provides a unique opportunity to better understand its molecular mechanisms and interactions within cellular pathways. Research involving the recombinant expression of DLEU1 aims to elucidate its functional roles, to investigate its potential as a therapeutic target, and to contribute to the development of novel diagnostic and prognostic tools in cancer management. Further investigations into DLEU1's interactions with other cellular components may reveal insights into its involvement in cancer pathophysiology, paving the way for future studies that could harness its properties for clinical applications, including targeted therapies and personalized medicine strategies in oncological contexts.